28.8MUSD
See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US6904691010
CUSIP
690469101
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
0.83
Dividend Share
-
Dividend Yield
-
Earnings Share
-0.34
Wall Street Target Price
3.10
EPS Estimate Current Year
-0.58
EPS Estimate Next Year
-0.63
EPS Estimate Current Quarter
-0.13
EPS Estimate Next Quarter
-0.1333
Most Recent Quarter
-
Revenue TTM
548,000
Gross Profit TTM
548,000
EBITDA
-52,900,000
Profit Margin
0.00%
Return On Assets TTM
-31.37%
Return On Equity TTM
-36.31%
Revenue Per Share TTM
0.008
Qtly Revenue Growth YOY
-12.20%
Diluted Eps TTM
-0.34
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
1
Price Sales TTM
47.7524
Price Book MRQ
0.4415
Enterprise Value Revenue
37
Enterprise Value EBITDA
0
577.92
4.02%322.98
3.84%277.51
2.90%81.44
1.94%468.00
0.87%548.99
0.23%547.60
0.00%203.85
0.00%99.06
-1.90%157.11
-1.81%